Skip to content

Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps

Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06459622
Enrollment
102
Registered
2024-06-14
Start date
2024-07-31
Completion date
2025-05-31
Last updated
2024-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Brief summary

The study will be conducted to identify factors predicting the response of chronic rhinosinusitis with nasal polyps ( CRSwNP) to oral corticosteroids.

Detailed description

Treatment of nasal polyposis is divided into medical or surgical treatment . Steroids are widely used as the most effective medicine in nasal polyposis. Although oral corticosteroids are one of the frequently used treatments in the management of chronic rhinosinusitis with nasal polyps (CRSwNP), there is lack of effective means of predicting corticosteroid sensitivity in those patients. It was reported that the overall sensitivity rates of corticosteroid therapy to nasal polyps( NP) were only between 53.8% and 80%.. Many reports stated that serum and tissue interleukeine 25 (IL 25) and serum and tissue eosinophalia are good predictors to the response of CRSwNP to oral corticosteroids. Interleukeine 25(IL-25), an important epithelial-derived proinflammatory cytokine, plays various roles in different inflammatory and allergic diseases, such as asthma and atopic dermatitis . Hong et al demonstrated that the levels of IL-25 in NP tissues and in serum, as well as the NP endoscopic scores, were significantly elevated in the corticosteroid-sensitive patients compared with the non-sensitive ones. In general, eosinophilic NPs are pharmacologically glucocorticoid responsive, but non-eosinophilic or neutrophilic CRSwNP is frequently resistant to steroid treatment.

Interventions

DIAGNOSTIC_TESTSerum IL_25 and eosinophils in nasal polyp tisuee

Serum IL-25 and eosinophils in nasal polyps tisuer obtained and measured to identify the sensitivity of nasal polyps to corticosteroids

Sponsors

Assiut University
CollaboratorOTHER
Katrina Atef Habashy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* clinical diagnosis of chronic rhinosinusitis with nasal polyps

Exclusion criteria

* 1-Patients who had taken any steroid , antihistamine or other immune-modulating medications within the past 4 weeks 2- previous nasal and sinus surgery. 3-Allergic Fungal rhinosinusitis. 4-Unilateral rhinosinusitis. 5- Antrochoanal polyps or cystic fibrosis.

Design outcomes

Primary

MeasureTime frameDescription
Serum IL-25 is measured to releave the relation between them and the response of CRSwNP to oral corticosteroidsBaselineSerum IL-25 is related to the effect of corticosteroids on CRSwNP

Other

MeasureTime frameDescription
Eosinophils in nasal polyp tissueBaselineEosinophils is related to the inflammatory process of CRSwNP

Contacts

Primary ContactKatrina Atef, General practitioner
Katyatef90@gmail.com01220058161
Backup ContactAlla Kamel, Professor
alaakamel@med.aun.edu.eg01005534200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026